View Older Stories
-
Viatris (VTRS) PT Raised to $17 at Barclays amid 'catalyst rich' FY26
-
Viatris receives Japan approval for Effexor to treat anxiety disorder
-
Viatris sets long-term targets through 2030 at investor event
-
Increasing unusual option volume: WOOF HIMX SKM BMBL VTRS
-
Viatris (VTRS) PT Raised to $20 at UBS on Cost-Savings Initiatives
-
Viatris (VTRS) PT Raised to $12 at BofA Securities
-
Viatris Inc (VTRS) Tops Q4 EPS by 3c, Beats on Revenue; Offers FY26 Guidance
-
FDA accepts Viatris drug application for presbyopia treatment
-
UBS Upgrades Viatris (VTRS) to Buy
-
Viatris names Matthew Maletta as chief legal officer
-
Viatris (VTRS) PT Raised to $12 at Piper Sandler
-
Viatris launches heart failure drug Inpefa in UAE
-
Argus Upgrades Viatris (VTRS) to Buy
-
Viatris names Lara Ramsburg as chief people and corporate affairs officer
-
Viatris receives FDA approval for generic Sandostatin plus 3 other milestones
-
Viatris to sell Biocon Biologics stake for $815 million
-
Viatris Inc (VTRS) Tops Q3 EPS by 5c, Beats on Revenue; Offers FY25 Guidance
-
Truist Securities Starts Viatris (VTRS) at Buy
-
Viatris names Andrew Enrietti as chief administrative and transformation officer
-
Viatris receives FDA approval for first generic iron sucrose injection
-
Viatris Inc (VTRS) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY25 Guidance
-
Viatris appoints David Simmons to board of directors
-
Goldman Sachs Reiterates Neutral Rating on Viatris (VTRS)
-
Goldman Sachs Reiterates Neutral Rating on Viatris (VTRS)
-
Viatris Inc (VTRS) Announces Positive Top-Line Results from Second Pivotal Phase 3 VEGA-3 Trial of MR-141
-
Goldman Sachs Starts Viatris (VTRS) at Neutral
-
VTRS Investors Have the Opportunity to Lead the Viatris Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
-
VTRS DEADLINE TODAY: Viatris Inc. Shareholders are Reminded of Today's June 3 Securities Class Action Deadline
-
VTRS DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - V
-
Viatris Inc (VTRS) Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
-
VTRS CLASS ALERT: Viatris Inc. Investors with Losses are Notified to Contact BFA Law before Tuesday's June 3 Securities Fraud Class Action Deadline
-
VTRS DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - V
-
VTRS FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - V
-
Faruqi & Faruqi Reminds Viatris Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - VTRS
-
VTRS DEADLINE TUESDAY: BFA Law Alerts Viatris Inc. Investors of the Pending June 3 Class Action Deadline
-
VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
-
VTRS DEADLINE: ROSEN, REGARDED INVESTOR COUNSEL, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - VTRS
-
VTRS SECURITIES UPDATE: Viatris Inc. Investors with Losses are Reminded of the Upcoming June 3 Securities Class Action Deadline
-
VTRS DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - VTRS
-
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
-
VTRS SECURITIES: BFA Law Notifies Viatris Inc. Investors to Contact the Firm about the Pending Securities Fraud Class Action by June 3
-
VTRS DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Acti
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
-
VTRS IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action
-
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
-
VTRS FRAUD NOTICE: Viatris Inc. Investors with Losses are Reminded to Contact BFA Law about the Pending Securities Fraud Class Action
-
VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS

